RM

Renjith Mani

Active Director Director DIN 09794763
DIN 09794763 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Renjith Mani

Data last updated:

Renjith Mani is a Director at Nemour Medical Centre Private Limited (since 2022). The company operates in Healthcare. Nemour Medical Centre Private Limited reported revenue of ₹47,110 (FY 2023).

DIN 09794763
Primary Designation Director
Industry Healthcare
First Appointment 17 Nov 2022
Oldest Company Age 4 yrs
Largest company Nemour Medical Centre Private Limited · ₹47,110 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 20222022₹47,110 (FY 2023)Active

Board colleagues of Renjith Mani

NameDINCompanyDesignation
Silja Arumugham Omana09794764Nemour Medical Centre Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nemour Medical Centre Private Limited
Premium access

Shareholding and investment profile for Renjith Mani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renjith Mani

Renjith Mani currently holds 1 directorship: Nemour Medical Centre Private Limited (Director, since 17 Nov 2022, revenue ₹47,110 (FY 2023)).

Renjith Mani was first appointed on 17 Nov 2022 as Director at Nemour Medical Centre Private Limited.

The current boards of Renjith Mani's companies include Silja Arumugham Omana (Nemour Medical Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available